CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with entecavir and tenofovir
David Sooik Kim, Mi Young Jeon, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seung Up Kim
    DOI: https://doi.org/10.3350/cmh.2018.0054

Excel Download

Tu1029 Hepatic Steatosis is a Causative Factor for Entecavir Treatment Failure in Chinese Patients With Chronic Hepatitis B
Gastroenterology. 2012;142(5):S-1015   Crossref logo
Link1 Link2

Exam 2: Similar Risk of Renal Events Among Patients Treated With Tenofovir or Entecavir for Chronic Hepatitis B
Clinical Gastroenterology and Hepatology. 2012;10(8):e68   Crossref logo
Link1 Link2

Mortality, liver transplantation and hepatic complications in patients with treatment-naïve chronic hepatitis B treated with entecavir vs tenofovir
Journal of Viral Hepatitis. 2018;25(12):1565-1575   Crossref logo
Link1 Link2

Partial Response to Entecavir and Tenofovir in Naïve Patients with Chronic Hepatitis B: Clinical Relevance and Management
Current Hepatitis Reports. 2012;11(2):90-94   Crossref logo
Link1 Link2 Link3

Response to tenofovir monotherapy in chronic hepatitis B patients with prior suboptimal response to entecavir
Journal of Viral Hepatitis. 2011;19(3):213-219   Crossref logo
Link1

Letter: distinct hepatitis B virus relapse rates after discontinuing tenofovir and entecavir therapy in chronic hepatitis B patients-author's reply
Alimentary Pharmacology & Therapeutics. 2019;49(8):1106-1107   Crossref logo
Link1 Link2

Efficacy and safety of entecavir versus tenofovir treatment in chronic hepatitis B patients: A randomized controlled trial
Hepatology Research. 2016;47(3):E161-E168   Crossref logo
Link1 Link2 Link3

Renal outcomes in chronic hepatitis b patients treated with tenofovir disoproxil fumarate or entecavir: a propensity score matched study
Journal of Hepatology. 2018;68:S519-S520   Crossref logo
Link1 Link2

250 - Renal Outcomes in Chronic Hepatitis B Patients Treated with Tenofovir Disoproxil Fumarate or Entecavir: A Propensity Score Matched Study
Gastroenterology. 2018;154(6):S-1081   Crossref logo
Link1 Link2

P677 HEPATIC STEATOSIS DOES NOT PREDICT REGRESSION OF LIVER CIRRHOSIS IN CHRONIC HEPATITIS B (CHB) PATIENTS TREATED WITH TENOFOVIR DISOPROXIL FUMARATE (TDF)
Journal of Hepatology. 2014;60(1):S294-S295   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.